Thompson Davis & Co., Inc. Insmed Inc Transaction History
Thompson Davis & Co., Inc.
- $112 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding INSM
# of Institutions
451Shares Held
171MCall Options Held
5.78MPut Options Held
5.15M-
Vanguard Group Inc Valley Forge, PA16MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$960 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$818 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA5.87MShares$395 Million0.08% of portfolio
-
State Street Corp Boston, MA4.66MShares$314 Million0.01% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.11B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...